Evidence map›Paper›PMID 26273791›Full record

Trial reportPediatric obesity2016

Effect of vitamin D3 treatment on endothelial function in obese adolescents.

A Javed, I J Kullo, P Babu Balagopal, S Kumar

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Pediatric obesity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01746264 (Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents), which is not on this map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01746264 phase1completednot on this map

Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents

TypeinterventionalSponsorMayo ClinicRan2012 to 2013Enrolled19ConditionsObesity, Endothelial Dysfunction, Vitamin D DeficiencyArmsVitamin D3
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Rare presentation of vitamin D toxicity with hypertriglyceridemia and pancreatitis.Endocrinology, diabetes & metabolism case reports · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Effects of Cashew Nut (Journal of nutrition and metabolism · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

A JavedDivision of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
I J KulloDivision of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
P Babu BalagopalDivision of Biomedical Research, Nemours Children's Clinic, Jacksonville, FL, USA.
S KumarDivision of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · USNemours Children’s Clinic · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
NCATS NIH HHS UL1 TR000135
6 · The paper itself

Abstract

backgroundObesity in children is associated with vitamin D deficiency and endothelial dysfunction. It is not known if treatment with vitamin D improves endothelial function in obese adolescents.

objectiveThis study aimed to determine whether treatment with vitamin D3 improves endothelial function in obese adolescents.

methodsNineteen obese adolescents, 13-18 years of age, with 25-hydroxy vitamin D (25[OH]D) levels <75 nmol L(-1) were treated with 100 000 IU vitamin D3 orally once a month for 3 months in an open-label, single-centre prospective trial. Endothelial function was assessed by flow-mediated dilatation (FMD) of the brachial artery at study entry and 1 month after the third dose of vitamin D3 . Biochemical parameters, including calcium, fasting lipids, glucose, insulin and high-sensitivity C-reactive protein, were also obtained.

resultsMean 25(OH)D levels increased from 55.9 ± 12.2 to 86.9 ± 16.7 nmol L(-1) (P < 0.01). There was no correlation between 25(OH)D levels and brachial artery FMD. The brachial artery FMD (%) did not change significantly following vitamin D3 treatment (9.5 ± 3.53 vs. 10.3 ± 3.83, P = 0.83). Serum parathyroid hormone declined from 3.8 ± 1.5 to 3.1 ± 1 pmol L(-1) (P = 0.01). The remainder of biochemical measurements did not show a significant change.

conclusionsTreatment with vitamin D3 , 100 000 IU once a month for 3 months was effective in increasing 25(OH)D levels in obese adolescents but did not impact endothelial function.

Indexed as

AdolescentBrachial ArteryCalciumCholecalciferolC-Reactive ProteinEndothelium, VascularFemaleHumansInsulinInsulin ResistanceLipidsMaleParathyroid HormonePediatric ObesityProspective StudiesVitamin D25-hydroxyvitamin DCalciumCholecalciferolC-Reactive ProteinInsulinLipidsParathyroid HormoneVitamin DAdolescentschildhood obesityendothelial functionvitamin D

Identifiers

PMID26273791
PMCPMC4753130
OpenAlexW1784684491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.